Author

Natsuko Inoue

Observed name: NATSUKO INOUE

Institution: Osaka Medical and Pharmaceutical University

Observed institutions: Hyogo Medical University, Osaka Medical and Pharmaceutical University, Kobe University

OpenAlex ID: A5111556029

Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population

2008 · Mayumi Kasahara, Kayo Osawa, et al. · Journal of Experimental & Clinical Cancer Research · 93

MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population

2009 · Aiko Miyaishi, Kayo Osawa, et al. · Journal of Experimental & Clinical Cancer Research · 63

Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer

2018 · Yoshikazu Johmura, Ichiro Maeda, et al. · Journal of Clinical Investigation · 61

Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers

2017 · Takahiro Watanabe, Akira I. Hida, et al. · Breast Cancer Research and Treatment · 37

Significant association between high serum CCL5 levels and better disease‐free survival of patients with early breast cancer

2019 · Yukie Fujimoto, Natsuko Inoue, et al. · Cancer Science · 34

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer

2014 · Ayako Yanai, Natsuko Inoue, et al. · Clinical Breast Cancer · 27

APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese.

2010 · Kayo Osawa, Aiko Miyaishi, et al. · PubMed · 26

High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer

2019 · NATSUKO INOUE, WEN LI, et al. · Anticancer Research · 24

Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers

2014 · Tomoko Yagi, Natsuko Inoue, et al. · Breast Cancer · 24

Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes

2020 · REIKO FUKUI, YUKIE FUJIMOTO, et al. · Anticancer Research · 19

IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through Notch signaling

2024 · Wen Li, Denan Jin, et al. · Journal of Leukocyte Biology · 12

Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers

2012 · Keiko Murase, Ayako Yanai, et al. · Breast Cancer · 12

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis

2013 · Tomohiro Miyake, Takashi Ito, et al. · Breast Cancer · 7

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers

2017 · Arisa Nishimukai, Natsuko Inoue, et al. · PLoS ONE · 6

Abstract PS4-20: Low levels of interleukin-6 at baseline were significantly associated with improved overall survival of patients treated with eribulin for locally advanced or metastatic breast cancer

2021 · Ayako Bun, Natsuko Inoue, et al. · Cancer Research

C4.4A and Aldehyde Dehydrogenase 1 (ALDH1) May Contribute to breast Cancer not Mediated Through epithelial-Mesenchymal Transition

2015 · Natsuko Inoue · International Journal of Cancer and Clinical Research

Works count: 16

Citation count: 445

H-index: 12

I10-index: 12